title: The immune status and response to measles vaccine amongst Egyptian infants. A preliminary report.
abstract: This study was carried out on 18 infants attending a primary care clinic in the Giza Governorate. Following a comprehensive history and physical exam estimation of measles antibody titer by neutralization testing was carried out on 10 infants prior to vaccination and on 8 infants prior to as well as one month following vaccination against measles utilizing the Edmondston-Zagreb strain. Our results indicate that at the currently adopted age of 9 months for vaccination, infants are susceptible to measles. Good response to vaccination with acquisition of immunity was noted despite border-line levels of growth and development. The occasional patient with persistent maternal antibodies to measles responded well to vaccination.
authors.affiliation: Department of Pediatrics, Cairo University.
authors.forename: S
authors.initials: S
authors.lastname: Abdel Hadi
authors.forename: R
authors.initials: R
authors.lastname: Hassan
authors.forename: M
authors.initials: M
authors.lastname: Hosny
authors.forename: L
authors.initials: L
authors.lastname: Farag
authors.forename: M
authors.initials: M
authors.lastname: Yassin
authors.forename: L
authors.initials: L
authors.lastname: Basiouny
authors.forename: S
authors.initials: S
authors.lastname: Lofty
authors.forename: M A
authors.initials: MA
authors.lastname: Attia
mesh_terms: D000914:Antibodies, Viral / Q000097:blood*; D000917:Antibody Formation / Q000276:immunology*; D004534:Egypt; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D008297:Male; D008458:Measles Vaccine / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D008458:Measles Vaccine